Featured Articles
-
The Bond Factor: Connecting For Success In Life Sciences
12/13/2024
Sanofi’s chief learning officer Wanda Shoer explains the importance of self-awareness about of your own core skills, talents, and values in becoming more adaptable and successful.
-
Optimism For Life Sciences Growth Amid Policy Shifts In 2025
12/11/2024
EY's Arda Ural provides an assessment of the current life sciences business environment, and reasons for optimism about 2025 despite the uncertainty that comes with a new administration in the U.S.
-
Leading Through Biotech's Perfect Storm: Lessons From The Front Lines
12/9/2024
Memo Therapeutics CEO Erik van den Berg reflects on the strategies and skills needed to build company resilience and navigate successfully through challenging external circumstances.
-
Four Ways For Legal Departments To Create Financial Efficiency
12/6/2024
Life sciences legal departments can do more to improve financial efficiency across an organization. This article includes insights from an Ernst & Young survey of multinational corporations across the pharmaceutical, consumer health, and medical device industries.
-
The Fork In The Road: Personal Decisions That Change Our Career Trajectory
12/4/2024
Novo Nordisk SVP Blandine Lacroix shares her career story and discusses the importance of prioritizing your own personal needs, and the personal needs of others, in navigating a professional career.
-
Where Are They Now? Teva Pharmaceuticals
11/29/2024
Teva Pharmaceuticals "pivot to growth" strategy under CEO Richard Francis aims to use a combination of biosimilars, generics, and branded drugs to set the company back on track, or back to the future.
-
FDA's Psychedelic Reckoning
11/27/2024
Cybin CEO Doug Drysdale discusses learnings from psychedelic drug clinical trial missteps, provides examples of the benefits of FDA breakthrough therapy designation, and talks about why RFK Jr. as HHS Secretary could be a win for psychedelic drug developers.
-
Companies To Watch: Terns Pharmaceuticals
11/26/2024
Terns Pharmaceuticals aims to improve upon currently marketed therapies in CML and obesity, using internally discovered small molecules.
-
Unraveling The Complexity Of Cell Therapy: Advancements And Challenges
11/26/2024
Cell therapy has emerged as a powerful tool for addressing critical medical challenges, but its rapid evolution necessitates a clear regulatory framework and consistent terminology.
-
How To Lead a Company That's Disrupting An Industry
11/22/2024
Pacira BioSciences CEO Frank D. Lee shares three core tenants to improve biopharmaceutical company leadership, especially companies with products capable of disrupting an established therapeutic area.